Related Experiment Videos
Risperidone in the treatment of schizophrenia
1West Los Angeles VA Medical Center, CA 90073.
The American Journal of Psychiatry
|June 1, 1994
Summary
The optimal daily dose of risperidone for schizophrenia is 6 mg, offering significant improvement in positive and negative symptoms with a safety profile comparable to placebo. This dose proved as effective as higher risperidone doses but with fewer side effects.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Neuroscience
Background:
- Schizophrenia is a complex mental disorder characterized by positive and negative symptoms.
- Antipsychotic medications are the cornerstone of schizophrenia treatment.
- Determining optimal dosage is crucial for balancing efficacy and safety.
Purpose of the Study:
- To evaluate the safety and efficacy of risperidone in treating schizophrenia.
- To identify the optimal daily dosage of risperidone.
- To compare risperidone's effects with placebo and haloperidol.
Main Methods:
- A double-blind, randomized study involving 388 schizophrenic patients.
- Treatment arms included placebo, four doses of risperidone (2, 6, 10, 16 mg), and 20 mg haloperidol.
- Study duration was 8 weeks, with assessments using the Positive and Negative Syndrome Scale for Schizophrenia and Extrapyramidal Symptom Rating Scale.
Main Results:
- The 6 mg dose of risperidone showed significant clinical improvement compared to placebo and haloperidol.
- Risperidone at 6, 10, and 16 mg effectively reduced positive symptoms; 6 and 16 mg also reduced negative symptoms.
- Higher doses (16 mg risperidone, 20 mg haloperidol) were associated with increased extra-pyramidal side effects compared to placebo.
Conclusions:
- Risperidone is a safe and effective antipsychotic for schizophrenia.
- The optimal daily dose of risperidone for most patients in this study was 6 mg.
- The 6 mg dose demonstrated efficacy comparable to higher doses with a similar side effect profile to placebo.